Gentium S.p.A. (NASDAQ: GENT), a biopharmaceutical company, specializes in discovering, researching, developing and manufacturing active ingredients derived from natural sources as potential therapeutic agents. The company focuses on developing relationships with industrial and academic institutions and intends to discover further beneficial effects of its products as well as develop pharmaceuticals with a broader range of treatment indications. For further information, visit the Company’s web site at http://www.gentium.com.
- 17 years ago
QualityStocks
Gentium S.p.A. (NASDAQ: GENT)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Why Micropolis Holding Co. (NYSE American: MCRP) Is ‘One to Watch’
Micropolis (NYSE American: MCRP) is a robotics and AI technology company pioneering the development of unmanned…
-
QualityStocksNewsBreaks – Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) Positioned in North America’s Critical Minerals Future
Trilogy Metals (NYSE American: TMQ) (TSX: TMQ) was featured in a recent article that discusses the…
-
QualityStocksNewsBreaks – Copper’s Moment: Nicola Mining Inc. (TSX.V: NIM) (OTCQB: HUSIF) Taps Rising Demand with BC Projects and Custom Mill
Nicola Mining (TSX.V: NIM) (OTCQB: HUSIF), a junior exploration and custom milling company, is poised…